Observational Study of Treatments for Liver Cancer at One Center
Reviews real-world outcomes of drug treatments in adults with liver cancer.
Plain-language title generated from the registry record
Registry title: Real-world Insight Into Systemic Therapies for HCC: Single-center Study
Key facts
- Where
- Al Mansurah, EgyptSee the site
Where in Egypt
- Mansoura University HospitalsAl Mansurah, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Mansoura University
- Trial code
- NCT07814014
- Record updated
- 10 September 2026
- Original description
Real-world data from a single-center experience evaluating patients with hepatocellular carcinoma (HCC) receiving systemic therapiesRead full original descriptionShow less
Real-world Insight Into Systemic Therapies for Hepatocellular Carcinoma: a Comprehensive Single-center Study
Real-world data from a single-center experience evaluating patients with hepatocellular carcinoma (HCC) receiving systemic therapies
Inclusion: patient with HCC; Child-Pugh class A, B7; Performance state 0-1 (Eastern Cooperative Oncology Group (ECOG scale); Barcelona Clinic Liver Cancer (BCLC) stage C or BCLC stage B with diffuse, infiltrative or extensive bilobar involvement or BCLC stage B with tumor progression after TACE.
Exclusion: Patients eligible for treatment other than systemic therapy according to Barcelona Clinic liver cancer; patient with other tumor than HCC; Child-Turcotte-Pugh score B (8,9) and C.